U.S. Said To Plan WTO Try To Overturn India CL Use On Bayer's Nexavar
This article was originally published in PharmAsia News
Executive Summary
The U.S. patent agency reportedly is considering a challenge to India's first compulsory-license action before the World Trade Organisation on grounds the move violated international trade laws.